Teva Pharmaceutical Industries (TEVA) Return on Invested Capital (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has 18 years of Return on Invested Capital data on file, last reported at 0.0% in Q2 2026.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, up 2.0% from the prior year.
• Return on Invested Capital eased to 0.0% in Q2 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q4 2025 to a low of 0.0% in Q4 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2022 — Return on Invested Capital changed 0 bps — and 2025, when it gained 1 bps.
• Tracing TEVA's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then soared by 132 bps to 0.0% in 2023, then sank by 238 bps to 0.0% in 2024, then surged by 1073 bps to 0.01% in 2025, then slumped by 75 bps to 0.0% in 2026.
• The last three Return on Invested Capital figures came in at 0.0% (Q2 2026), 0.01% (Q1 2026), and 0.01% (Q4 2025), per Business Quant data.